Work

Reduced gene dosage is a common mechanism of neuropathologies caused by ATP6AP2 splicing mutations

Year: 2022

Type: article

Source: Parkinsonism & Related Disorders

DOI: 10.1016/j.parkreldis.2022.06.015

Authors: William C. Edelman, Kostantin Kiianitsa, Tuhin Virmani, Refugio A. Martinez, Jessica E. Young, C. Dirk Keene, Thomas D. Bird, Wendy H. Raskind, Olena Korvatska

Institutions: University of Washington, University of Arkansas for Medical Sciences, VA Puget Sound Health Care System, Mental Illness Research, Education and Clinical Centers

Language: English

Topic: RNA Research and Splicing

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Veterans Affairs, Clinical Science Research and Development, National Institute on Aging, National Institute of Neurological Disorders and Stroke, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G3135171386, G3278543091, G5083024019, Intellectual and Developmental Disabilities Research Center, Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease, University of Washington Alzheimer's Disease Research Center

OpenAlex ID: W4283370652

FWCI: 0.327

Cites: 25

Cited by: 5

Related to: 10